Home >> Research Area >>Natural Products>>Triterpenoids>> Ganoderic acid C1

Ganoderic acid C1

CAS# 95311-97-0

Ganoderic acid C1

Catalog No. BCN3035----Order now to get a substantial discount!

Product Name & Size Price Stock
Ganoderic acid C1: 5mg $213 In Stock
Ganoderic acid C1: 10mg Please Inquire In Stock
Ganoderic acid C1: 20mg Please Inquire Please Inquire
Ganoderic acid C1: 50mg Please Inquire Please Inquire
Ganoderic acid C1: 100mg Please Inquire Please Inquire
Ganoderic acid C1: 200mg Please Inquire Please Inquire
Ganoderic acid C1: 500mg Please Inquire Please Inquire
Ganoderic acid C1: 1000mg Please Inquire Please Inquire
Related Products

Quality Control of Ganoderic acid C1

Number of papers citing our products

Chemical structure

Ganoderic acid C1

3D structure

Chemical Properties of Ganoderic acid C1

Cas No. 95311-97-0 SDF Download SDF
PubChem ID 471004 Appearance Powder
Formula C30H42O7 M.Wt 514.7
Type of Compound Triterpenoids Storage Desiccate at -20°C
Solubility Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc.
Chemical Name (2R,6R)-6-[(5R,7S,10S,13R,14R,17R)-7-hydroxy-4,4,10,13,14-pentamethyl-3,11,15-trioxo-1,2,5,6,7,12,16,17-octahydrocyclopenta[a]phenanthren-17-yl]-2-methyl-4-oxoheptanoic acid
SMILES CC(CC(=O)CC(C)C(=O)O)C1CC(=O)C2(C1(CC(=O)C3=C2C(CC4C3(CCC(=O)C4(C)C)C)O)C)C
Standard InChIKey YTVGSCZIHGRVAV-NJNFCIENSA-N
Standard InChI InChI=1S/C30H42O7/c1-15(10-17(31)11-16(2)26(36)37)18-12-23(35)30(7)25-19(32)13-21-27(3,4)22(34)8-9-28(21,5)24(25)20(33)14-29(18,30)6/h15-16,18-19,21,32H,8-14H2,1-7H3,(H,36,37)/t15-,16-,18-,19+,21+,28+,29-,30+/m1/s1
General tips For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months.
We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months.
Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it.
About Packaging 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial.
2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial.
3. Try to avoid loss or contamination during the experiment.
Shipping Condition Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request.

Source of Ganoderic acid C1

The fruit body of Ganoderma lucidum

Biological Activity of Ganoderic acid C1

Description1. Ganoderic acid C1 inhibits histamine release. 2. Ganoderic acid C1 has anti-tumor-promoting activity. 3. Ganoderic acid C1 is moderately active inhibitors against HIV-1 protease. 4. Ganoderic acid C1 has anti-inflammatory activity, has potential for treating TNF-α mediated inflammation in asthma and other inflammatory diseases.
TargetsNF-kB | MAPK | AP-1 | TNF-α | IFN-γ | IL Receptor | HIV

Ganoderic acid C1 Dilution Calculator

Concentration (start)
x
Volume (start)
=
Concentration (final)
x
Volume (final)
 
 
 
C1
V1
C2
V2

calculate

Ganoderic acid C1 Molarity Calculator

Mass
=
Concentration
x
Volume
x
MW*
 
 
 
g/mol

calculate

Preparing Stock Solutions of Ganoderic acid C1

1 mg 5 mg 10 mg 20 mg 25 mg
1 mM 1.9429 mL 9.7144 mL 19.4288 mL 38.8576 mL 48.572 mL
5 mM 0.3886 mL 1.9429 mL 3.8858 mL 7.7715 mL 9.7144 mL
10 mM 0.1943 mL 0.9714 mL 1.9429 mL 3.8858 mL 4.8572 mL
50 mM 0.0389 mL 0.1943 mL 0.3886 mL 0.7772 mL 0.9714 mL
100 mM 0.0194 mL 0.0971 mL 0.1943 mL 0.3886 mL 0.4857 mL
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations.

Organizitions Citing Our Products recently

 
 
 

Calcutta University

University of Minnesota

University of Maryland School of Medicine

University of Illinois at Chicago

The Ohio State University

University of Zurich

Harvard University

Colorado State University

Auburn University

Yale University

Worcester Polytechnic Institute

Washington State University

Stanford University

University of Leipzig

Universidade da Beira Interior

The Institute of Cancer Research

Heidelberg University

University of Amsterdam

University of Auckland
TsingHua University
TsingHua University
The University of Michigan
The University of Michigan
Miami University
Miami University
DRURY University
DRURY University
Jilin University
Jilin University
Fudan University
Fudan University
Wuhan University
Wuhan University
Sun Yat-sen University
Sun Yat-sen University
Universite de Paris
Universite de Paris
Deemed University
Deemed University
Auckland University
Auckland University
The University of Tokyo
The University of Tokyo
Korea University
Korea University
Featured Products
New Products
 

References on Ganoderic acid C1

Anti-inflammatory Effects of Ganoderma lucidum Triterpenoid in Human Crohn's Disease Associated with Downregulation of NF-kappaB Signaling.[Pubmed:25993687]

Inflamm Bowel Dis. 2015 Aug;21(8):1918-25.

BACKGROUND: Crohn's disease (CD) is a chronic inflammatory disease of the gastrointestinal tract. Current medications have potentially serious side effects. Hence, there is increasing interest in alternative therapies. We previously demonstrated the anti-inflammatory effects of Food Allergy Herbal Formula-2 in vitro on peripheral blood mononuclear cells (PBMCs) and mucosa from CD subjects. Here, we investigated the anti-inflammatory effects of a bioactive compound isolated from Ganoderma lucidum (G. lucidum), a key herbal constituent of Food Allergy Herbal Formula-2, in CD in vitro. METHODS: Triterpene Ganoderic acid C1 (GAC1) was isolated from G. lucidum. Stimulated RAW 264.7 macrophages were treated with GAC1. Human PBMCs and colonic biopsies were obtained from children with CD and cultured with or without GAC1. TNF-alpha and other proinflammatory cytokine levels were measured in the culture supernatant. NF-kappaB signaling was investigated in PBMCs and colonic mucosa treated with GAC1 by In-Cell Western and Western blot analysis. RESULTS: GAC1 decreased TNF-alpha production by macrophages and PBMCs from CD subjects. GAC1 significantly decreased TNF-alpha, IFN-gamma, and IL-17A production by inflamed colonic biopsies from CD subjects. These effects were due to downregulation of the NF-kappaB signaling pathway. CONCLUSIONS: GAC1 inhibited production of TNF-alpha and other proinflammatory cytokines by PBMCs and inflamed CD colonic mucosa due to blockage of NF-kappaB activation. GAC1 is a key beneficial constituent in G. lucidum and the Food Allergy Herbal Formula-2 in suppressing the inflammatory cytokines found in CD and warrants clinical investigation for the treatment of CD.

Ganoderic acid C1 isolated from the anti-asthma formula, ASHMI suppresses TNF-alpha production by mouse macrophages and peripheral blood mononuclear cells from asthma patients.[Pubmed:26004313]

Int Immunopharmacol. 2015 Aug;27(2):224-31.

Asthma is a heterogeneous airway inflammatory disease, which is associated with Th2 cytokine-driven inflammation and non-Th2, TNF-alpha mediated inflammation. Unlike Th2 mediated inflammation, TNF-alpha mediated asthma inflammation is generally insensitive to inhaled corticosteroids (ICS). ASHMITM, aqueous extract of three medicinal herbs-Ganoderma lucidum (G. lucidum), Sophora flavescens Ait (S. flavescens) and Glycyrrhiza uralensis Fischer (G. uralensis), showed a high safety profile and was clinically beneficial in asthma patients. It also suppresses both Th2 and TNF-alpha associated inflammation in murine asthma models. We previously determined that G. uralensis flavonoids are the key active compounds responsible for ASHMITM suppression of Th2 mediated inflammation. Until now, there are limited studies on anti-TNF-alpha compounds presented in ASHMITM. The objective of this study was to isolate and identify TNF-alpha inhibitory compounds in ASHMITM. Here we report that G. lucidum, but not the other two herbal extracts, S. flavescens or G. uralensis inhibited TNF-alpha production by murine macrophages; and that the methylene chloride (MC)-triterpenoid-enriched fraction, but not the polysaccharide-enriched fraction, contained the inhibitory compounds. Of the 15 triterpenoids isolated from the MC fraction, only Ganoderic acid C1 (GAC1) significantly reduced TNF-alpha production by murine macrophages (RAW 264.7 cells) and peripheral blood mononuclear cells (PBMCs) from asthma patients. Inhibition was associated with down-regulation of NF-kappaB expression, and partial suppression of MAPK and AP-1 signaling pathways. Ganoderic acid C1 may have potential for treating TNF-alpha mediated inflammation in asthma and other inflammatory diseases.

Keywords:

Ganoderic acid C1,95311-97-0,Natural Products, buy Ganoderic acid C1 , Ganoderic acid C1 supplier , purchase Ganoderic acid C1 , Ganoderic acid C1 cost , Ganoderic acid C1 manufacturer , order Ganoderic acid C1 , high purity Ganoderic acid C1

Online Inquiry for:

      Fill out the information below

      • Size:Qty: - +

      * Required Fields

                                      Result: